Decision/Other
Adopted
李嘉誠向三間醫院提供30個組織碎化技術腎臟癌臨床試驗名額
Li Ka Shing is funding 30 clinical trial places at three Hong Kong hospitals so patients with kidney cancer can be treated with histotripsy, making Hong Kong the first city in Asia to run such a trial.
Trajectories
Mine up to three arcs for this record — target, direction, probability, horizon.
Actors and targets
Source
李嘉誠將向香港中文大學醫院、港怡醫院及養和醫院提供30個臨床試驗名額
Not established
- Total funding amount
- Trial duration and end date
- Patient eligibility criteria
- Whether the 30 places are split evenly among the three hospitals
Extracted detail
Related decisions
Same kind only, ranked by embedding similarity to this record.